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ABSTRACT

Luminescent quantum dot nanoparticles have emerged as a highly effective
alternative to organic fluorescence probes in a variety of applications employing the use of
immunoconjugates. In the present study, we have successfully used quantum dot technology
for the immunofluorescent detection of intracellular stages of Toxoplasma gondii in a CV-1
mammalian cell line. This assay will allow us to investigate the question of whether selenium
and other antioxidants have a direct impact on the intracellular cycle of the parasite. A LabTek cell culture system was used to determine optimal concentrations of primary and
secondary antibodies. Infected CV-1 monolayers were fixed in 4% formalin and cell
membranes were permeabilized with detergent prior to blocking and immune-labeling. The
use of a mouse anti-T. gondii primary antiserum followed by quantum dot – conjugated
secondary antibody (Goat anti-mouse IgG) resulted in a punctuate, intensely bright
fluorescent labeling of intracellular tachyzoite stages with no evidence of photobleaching or
fading. In addition, the application of cover slips using Cryoseal Mounting Media 60,
allowed for the long term storage of stained slide preparations.

INDEX WORDS: Immunology, Parasitology, Toxoplasma gondii, Quantum Dot
Technology, Immuno-fluorescence
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INTRODUCTION
Toxoplasma gondii is an Apicomplexan protozoan parasite that causes a disease
known as toxoplasmosis. Infection is generally chronic and asymptomatic in individuals with
a strong immune system. On the other hand, infection can be reactivated in individuals who
are immunocompromised, causing various types of neuropathology. Toxoplasma gondii
infection is also an important cause of miscarriage in pregnant women, and serious birth
defects in newborns. Toxoplasmosis is prevalent worldwide in many mammalian species as
well as birds. Cats are the only definitive host for this parasite. T. gondii has three stages in
its life cycle: tachyzoites, present during the acute phase of infection; bradyzoites, present
within tissue cysts during the chronic phase of infection; and oocysts produced during the
sexual cycle within the gastrointestinal tract of cats. Tachyzoites have a crescent shape, and
they do not have a visible way of locomotion such as pseudopodia, flagellum or cilia. They
enter host cells by penetrating through the host cell plasma membrane or by inducing
phagocytosis. After entry of tachyzoites into a host cell, there is a variable lag period before
the parasite divides, and this lag phase is partly parasite strain dependent (Dubey et al, 1998;
see Figure 1).
Previous studies in our laboratory determined the impact of vitamin E and selenium
supplementation in a murine model of toxoplasmosis. Results showed that increased dietary
supplementation with these two antioxidants resulted in trends towards increased tissue cyst
number, tissue pathology, and weight loss (McCarthy and Davis, 2003). These results were
surprising, since dietary supplementation with antioxidants such as vitamin E and selenium
generally results in an enhancement of the immune response, resulting in increased
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resistance to a variety of pathogens as well as tumors in animal models and in humans
(McCarthy and Davis, 2003). An important question that emerged from our antioxidant
study was whether vitamin E and selenium might have direct effects on the intracellular
cycle of T. gondii. We decided to first investigate the impact of selenium exposure on the
intracellular cycle of the parasite. My role in this investigation was to develop and optimize
an in vitro cell culture model of infection that would allow us investigate this question. This
study was conducted using the ME49 strain of T. gondii and a CV-1 (African Green
Monkey Kidney) mammalian cell line. An indirect immunofluorescence assay utilizing
Quantum Dot technology was also developed to allow for accurate visualization and
quantification of intracellular stages of the parasite.
Quantum Dots (QD) are nanometer-sized functional particles that display crystals of
semiconductor materials, which makes them well suited for visualization and tracking
(Pathak et al., 2005). They posses a core-shell material, such as CdSe coated with ZnS, and
are further coated by a polymer shell that allows the materials to be conjugated to biological
molecules (Lee and et al., 2004). Scientists have developed hybrid functionalized QDsliposome nanoparticles and have found that they are efficiently taken up by living cells
without causing cell death. Therefore, QDs can be used as fluorescent probes for ex vivo celllabeling studies with most types of water-soluble QD without further modifications (Figure
2). Luminescent quantum dot nanoparticles also have emerged as a highly effective
alternative to organic fluorescence probes in a variety of applications employing the use of
immuno-conjugates. Quantum Dots (QDs) are able to overcome some of the limitations
commonly encountered with organic fluorophores such as fading and low signal strength
(Lee and et al., 2004; Howarth et al., 2005). Brighter signals have been reported in
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experiments with QD than organic dyes due to greater adsorption of the excitation light and
the high photobleaching threshold in QDs (Lee and et al., 2004). Also, QDs offer advantages
such as higher quantum yield, a narrow, tunable and symmetric emission spectrum, and allow
in vivo imaging.
Quantum dot-conjugated antibodies have been successfully used for the detection of
Cryptosporidium parvum and Giardia lamblia in water samples (Zhu et al., 2004). Another
study conducted by Tokumasu and Dvorak (2003) demonstrated the applicability of QD
technique to the study of erythrocyte membrane modifications that occur during invasion by
Plasmodium spp, the causative agent of malaria. Quantum Dots have also been successfully
used to detect C. parvum oocytes. The study conducted by Lee et al. in 2004, clearly
demonstrated that QDs are highly photostable when compared to other organic dyes such as
Alexa 488-streptavidin, FITC, and EPA. Immunofluorescent detection of C. parvum oocytes
using QD-conjugated antibodies was shown to be a highly specific, sensitive, and
photostable.
In the present study, we adapted QD technology for the immunofluorescent detection
of intracellular stages of T. gondii in CV-1 cells. The primary goal of the present study was
to develop and optimize a Quantum Dot immuno-conjugate technique that would allow for
reliable, photo-stable detection of intracellular stages of Toxoplasma gondii in an in vitro
model of infection.
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Figure 1. Life cycle of Toxoplasma gondii (from Cambridge University Website)

Figure 2. Examples of QDs’ bioanalytical and biomedical applications. (from International
Journal of Molecular Science)
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MATERIALS AND METHODS
Cell cultures:
An African Green Monkey Kidney cell line (CV-1) was used for all in vitro cell culture
experiments. The cells were maintained in sterile RPMI-1640 medium, supplemented with
10% newborn calf serum and penicillin-streptomycin (all culture reagents from Sigma
Chemical Company, St Louis, Mo.). The cells were grown in T75 T flasks and were
incubated at 37ºC with high humidity and 5% CO 2 .

Parasites:
The parasite strain used in this study was the Toxoplasma gondii ME49 strain. The ME49
strain is maintained in our laboratory by passage in Swiss Webster mice and by infection of
CV-1 cell monolayers with tachyzoite stages of the parasite.

Preparation of cells for immunofluorescence assay (IFA):
After infected CV-1 cells reached confluency, they were harvested from T flasks using sterile
ethylenediaminetetraacetic acid buffer (EDTA). Culture supernatants were removed from
each T flask, and cells were incubated in the presence of 5 ml of sterile EDTA for 5-10
minutes at 37oC. Once cells had visibly detached from the T flask, 5mL of complete RPMI1640 was added to each flask, and the cells were resuspended by repeated pipetting. The
resulting cell suspension was then placed into a sterile 15ml centrifuge tube and the tube was
subjected to centrifugation for 5 minutes at 2000rpm. After decanting the supernatant, the
cell pellet was re-suspended in 4ml of RPMI-1640. The infected cells were counted using a
hemacytometer, and the concentration of cells was adjusted to 1.7 x106 cells/ml.
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Antibody reagents:
The primary antibody used in the Quantum-dot immunofluourescence assay (Q dot assay)
was mouse anti-Toxoplasma gondii. Mice in the chronic stages of infection with the ME49
strain of T. gondii were anesthetized with the inhalant anesthesia isoflurane. Blood was
obtained by cardiac puncture, and was allowed to clot overnight at 4oC. Sera were then
aliquoted and frozen at -20oC until use. The secondary antibody used in all Q dot assays was
goat anti-mouse IgG conjugated to fluorescent Quantum dots (Invitrogen Corporation,
Carlsbad, CA). The control primary antibody used in each assay was normal mouse serum.

Lab tech slides:
Lab Tek Chamber Slides (VWR Corporation, West Chester, PA) were used for all Q dot
assays. In preparation for the assay, each of the 8 wells on the slide was filled with 250"l of
the infected cell suspension at a concentration of 1.7 x 106 cells/mL. Cells were cultured
overnight at 37oC in a CO 2 incubator to allow the attachment of the cells to the slide.

Q dot assay:
Fixation and permeabilization
The supernatant of all wells was decanted. Wells were rinsed with 250"l of 1X phosphate
buffered saline (PBS), and then decanted. Cultured cells were fixed with 4% formalin in PBS
for 15 minutes. After the 15 minutes incubation, each chamber was washed twice with PBS.
Cells membranes were permeabilized with 0.25% Triton X (Sigma Chemical Co.) in PBS for
15 minutes, followed by two washes with PBS. Cells were incubated in a humidity chamber
with blocking buffer (5% Nonfat Dry Milk in PBS) overnight at 4oC. Wells were then
6

washed 3 times in PBS, with 5 minute intervals. Cells monolayers were incubated with
mouse anti-T. gondii antiserum or normal mouse serum for 1 hour at 37oC (at dilutions
ranging from 1/25 to 1/100 in blocking buffer). Wells were then washed 3 times in PBS, with
5 minute intervals. Incubation followed with Q dot conjugated secondary antibody (Quantum
dot conjugated goat anti- mouse IgG) for 1 hour at 37oC (at dilutions of 1/500 or 1/1000).
Chambers were removed from slides, and slides were washed 3 times in PBS, with 5 minutes
intervals. Glycerol was added to each slide, and a cover slip was then mounted on the slide.

Imaging
Slides were viewed on a Zeiss microscope equipped with epifluorescence. Stained cells were
viewed and photographed at various magnifications (primarily 400X and 1000X) using oilimmersion lenses with a camera mounted on the microscope.
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RESULTS

In vitro cell culture model of T. gondii infection
The CV-1 (African Green Monkey Kidney) cell line was successfully grown in T-75
flasks and on LabTek culture slides in the laboratory, and proved to be an excellent in vitro
model for monitoring the intracellular cycle of T gondii infection (Figure 3). The CV-1 cell
line was readily infected with tachyzoite stages of T. gondii, and high numbers of tachyzoite
stages could be obtained from culture supernatants within two weeks following infection.

Figure 3. CV-1 cells infected with tachyzoite stages of T. gondii. Note the
numerous tachyzoite stages indicated by arrows. (400X)

Control immunofluorescence assays
Initial assays were performed without primary antibody to determine if there would
be non-specific binding of the Quantum Dot conjugated secondary antibody. No non-
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specific binding of secondary antibody was observed at dilutions of 1/500 or 1/1000 in the
absence of primary antiserum. (see Figure 4).

Immunostaining of intracellular tachyzoite stages of Toxoplasma gondii
Different concentrations of both primary and secondary antibodies were tested in
indirect immunofluorescence assays (IFAs) to find the optimal conditions for staining
intracellular tachyzoite stages. As described above, CV-1 cells infected with tachyzoite
stages of T.gondii were grown in Lab-Tek culture slides with eight chambers. In the first test
series, a two-fold dilution of primary antibody (mouse anti-T. gondii or normal mouse serum)
was used ranging from 1/50 to 1/400. Cells in the top row of four chambers were exposed to
normal mouse serum. Cells in the bottom row of four chambers were exposed to the same
dilutions of mouse anti-T. gondii antiserum. Duplicate Lab-Tek slides were then exposed to
dilutions of either 1/500 or 1/1000 of the QD-conjugated secondary antibody. In a second
assay, a two-fold dilution of primary antibody (mouse anti-T. gondii or normal mouse serum)
was used ranging from 1/20 to 1/100, with QD-conjugated secondary antibody dilutions at
1/500 and 1/1000. Dilutions that showed the greatest fluorescence intensity and specificity,
with the lowest background staining were the dilutions with 1/50 or 1/100 primary antiserum
and 1/500 or 1/1000 QD-conjugated secondary antibody. These dilutions of primary and
secondary antibodies yielded intensely bright, punctate, fluorescent staining at both 400X
and 1000X magnification without background fluorescence. Representative IFA assay results
are shown in Figures 5-8.
The Quantum Dot Immunoconjugate allowed for the reliable, photo-stable detection
of intracellular stages of Toxoplasma gondii. Fluorescent staining of tachyzoite stages
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remained highly photostable even after several minutes of continuous illumination. No
evidence of photo-bleaching was observed in our assays, even in the absence of anti-fade
reagents. In addition, fluorescence intensity remained strong even when viewing slides that
had been stored for a period of several weeks. Quantum dot fluorescence appears to be stable
for weeks – months.

Figure 4. Control Immunofluorescence Assay, CV-1 cells infected with T. gondii. No
primary antibody, 1/500 dilution of secondary antibody (Goat anti-mouse Ig – Quantum Dot
conjugated). Slides were viewed and photographed using a Zeiss fluorescent microscope.
Image shown in black/white.
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Figure 5. Indirect Immunofluorescence Assay, CV-1 cells infected with T. gondii.
Normal Mouse Serum (1/50), 1/500 dilution of secondary antibody (Goat anti-mouse Ig –
Quantum Dot conjugated). Left panel shown in black/white, Right panel shown in color.

Figure 6. Indirect Immunofluorescence Assay, CV-1 cells infected with T. gondii.
Mouse Anti-T.gondii (1/100 dilution), 1/500 dilution of secondary antibody (Goat anti-mouse
Ig – Quantum Dot conjugated). This image depicts a cell heavily infected with tachyzoite
stages of T. gondii. Note intense immuno-staining of tachyzoite stages located around the
nucleus of the infected cell. Magnification 1000X.
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Figure 7. Indirect Immunofluorescence Assay, CV-1 cells infected with T. gondii.
Mouse Anti-T.gondii (1/100 dilution), 1/500 dilution of secondary antibody (Goat anti-mouse
Ig – Quantum Dot conjugated). Paired Nomarski (left) and fluorescent (right) images of
heavily infected T. gondii –infected CV-1 cells. Cells shown in the same field of view.
400X magnification

Figure 8. Indirect Immunofluorescence Assay, CV-1 cell infected with T. gondii. Mouse
Anti-T.gondii (1/100 dilution), 1/500 dilution of secondary antibody (Goat anti-mouse Ig –
Quantum Dot conjugated). This image depicts a CV-1 cell containing tachyzoite stages of T.
gondii. Note intense, punctate, immuno-staining of tachyzoite stages located around the
nucleus of the infected cell. Magnification 1000X.
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DISCUSSION
In this study, we successfully adapted QD technology for the immunofluorescent
detection of intracellular stages of T. gondii in CV-1 cells. Quantum Dots have been proven
to be useful in immunofluorescence assays because of their photostability, lack of photobleaching, and ease of conjugation to immunoglobulins. In many applications, QDs have
been shown to be far superior to conventional organic dyes. In the present study we
confirmed that QDs are highly photo-stable and highly resistant to photo-bleaching. Strong
fluorescent labeling was still visible for weeks and even months after the initial staining and
fixing of the slides.
QDs also have been shown to be useful in a variety of other immuno-labeling studies.
QD-conjugated antibodies were successfully used for the detection of Cryptosporidium
parvum and Giardia lamblia in water samples (Zhu et al., 2004). Two strategies were used.
In one of the strategies, the target cells were first bound to biotinylated antibodies before
conjugation of QDs to the cell-bound antibodies. In the second strategy, the authors’ used the
manufacturer’s recommended staining protocol and the QDs were linked to the antibodies
prior to addition to the samples. The authors reported that QDs showed better photo-stability
and higher brightness than the two most commonly used commercial staining kits: a A100DF
AquaGlo Dual Fluorochrome Kit and a KR1 Crypto-Cel IF test kit. The cells stained with the
organic dyes bleached rapidly under continuous UV exposure. In contrast, cells labeled with
QDs remained photostable after 5 minutes of continuous exposure to UV light. QDs also
facilitated a dual-color labeling for C .parvum and G .lamblia from various water sources
(Zhu et al., 2004)
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Quantum dots have also been used to label erythrocyte membranes and to identify
modifications occurring in the plasma membrane at the time of infection with Plasmodium
spp. A QD (QD 650) suspension was diluted to a final concentration of 10-15nM 10 minutes
prior to use. Erythrocytes were incubated with the QD suspension for 30 minutes. In order to
label the intracellular malarial stages, 0.1ug ml-1 of a Hoechst 33258 solution containing
10ug mL-1 of NaN 3 was added to the second wash in the assay. A direct comparison of
Alexa 568 and QD 605 was performed. A 50% decrease in fluorescence was observed in the
erythrocytes labeled with Alexa 568 after 10 seconds of continuous UV irradiation. In
contrast, there was no measurable decrease in fluorescence intensity in the QD labeled
erythrocytes, even after 20 minutes continuous irradiation. In the same study, merozoite
stages of P. falciparum were also successfully labeled with QD conjugated antibody. This
immunochemical study was important in furthering our understanding of the intraerythrocyte cycle of malaria (Tokumasu and Dvorak, 2003)
Quantum Dots also have been used successfully for the labeling of C. parvum oocytes
using QD605-streptavidin together with biotinylated anti-Crypstosporidium monoclonal
antibody (MAb). The immunofluorescent detection of C. parvum oocytes using QDconjugated antibodies was shown to be a highly specific, sensitive, and photostable (Lee et
al., 2004).
In the present study, we have successfully developed and optimized an in vitro cell
culture model of T. gondii infection that will allow future investigators to readily evaluate the
infectivity and intracellular replication rate of the parasite. The CV-1 cell line was
successfully grown in a complete RPMI-1640 medium, and proved to be an excellent host
cell model for the analysis of the intracellular cycle of T. gondii. The large size of the cells,
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and their extended and flattened morphology, allowed for the unambiguous visual detection
of QD-labeled tachyzoite stages. Different concentrations of both primary and secondary
antibodies were tested in indirect immunofluorescence assays (IFAs) to find the optimal
conditions for staining intracellular stages. The optimal concentrations were found to be 1/50
and 1/100 dilution of the primary antibody (mouse anti-T. gondii), together with 1/500 or
1/1000 dilutions of secondary antibody (goat anti-mouse Ig – Quantum Dot conjugated).
The present study is the first to report of the use of QD technology for the immunofluorescent detection of intracellular tachyzoite stages of T. gondii. The development and
optimization of this technique has successfully paved the way for future investigators in the
laboratory to investigate the impact of selenium and vitamin E exposure on the intracellular
cycle of T. gondii.
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